Mont-Saint-Guibert, Belgium – 26th January, 2021 – Nyxoah SA (Euronext: NYXH) (“Nyxoah” or the “Company”), a health-technology company focused on the development and commercialization of innovative solutions and services to treat Obstructive Sleep Apnea (OSA), today announces the Company has received CE Mark Magnetic Resonance Imaging (MRI) conditional labeling for the current Genio® neurostimulation-based OSA […]
Category Archives: Press Releases
Aplidium albicans First studies reported on antiviral drug effects against new variant mutant “U.K.” strain of SARS-CoV-2 Plitidepsin shows potent anti-viral effect in preclinical models of original SARS-CoV-2 as well as the new mutant U.K. strain, and by inhibiting a key host protein, has the potential to have antiviral activity against other future mutations and […]
Aplidium albicans First studies reported on antiviral drug effects against new variant mutant “U.K.” strain of SARS-CoV-2 Plitidepsin shows potent anti-viral effect in preclinical models of original SARS-CoV-2 as well as the new mutant U.K. strain, and by inhibiting a key host protein, has the potential to have antiviral activity against other future mutations and […]
January 25, 2021 Two major randomized controlled trials (RCTs) show no difference in mortality between patients treated with the Philips Stellarex drug-coated balloon (DCB) and those treated with percutaneous angioplasty (PTA), the current standard of care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the […]
Samsung Bioepis New Headquarters Located in Korea’s ‘Bio Cluster’ of Songdo in the Incheon Free Economic Zone (IFEZ) The 52,000-square-foot campus to become the hub of Samsung Bioepis’ drive for accelerated development of next-generation biologic medicines Includes ‘Welfare Center’ with cafeteria, in-house fitness center, and a daycare center A photo accompanying this announcement is available […]
January 25, 2021 5-year alliance will provide Vithas Group with state-of-the-art diagnostic imaging, image viewing solutions, and minimally-invasive intervention technology to deliver faster and more accurate diagnosis and treatment to patients Vithas will become a ‘reference technology partner’ for Philips in Spain, giving it fast access to advances and innovations that Philips develops prior to […]
January 25, 2021 Hospital will have access to Philips’ latest technologies and informatics solutions to enhance the diagnosis, treatment, monitoring and management of patients Multi-year strategic partnership will accelerate clinical research focused on image-guided minimally-invasive therapy, neurology, intensive care units and digital pathology Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global […]
January 25, 2021 Fourth-quarter highlights • Sales amounted to EUR 6.0 billion, with 7% comparable sales growth • Comparable order intake increased 7% • Income from continuing operations increased to EUR 608 million, compared to EUR 550 million in Q4 2019 • Adjusted EBITA margin increased to 19.0% of sales, compared to 17.9% of sales […]
SHANGHAI, China, Jan. 25, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), an innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that U.S. Food and Drug Administration (FDA) has granted toripalimab Fast Track designation for the first-line treatment of mucosal melanoma. Meanwhile, the FDA has also […]
SHANGHAI, China, Jan. 25, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), an innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that U.S. Food and Drug Administration (FDA) has granted toripalimab Fast Track designation for the first-line treatment of mucosal melanoma. Meanwhile, the FDA has also […]